NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of ...
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, will highlight the latest sudden cardiac death research, case experiences for heart failure readmission ...
Bristol Myers Squibb (NYSE: BMY) today announced the presentation of new clinical trial and real-world data for Camzyos ...
Picard Medical, Inc. (NYSE American: PMI) (the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, ...
Please provide your email address to receive an email when new articles are posted on . The American College of Cardiology Scientific Session will take place April 6 to 8 in Atlanta. This year also ...
As medical knowledge now doubles every 73 days, the challenge for cardiology clinicians has shifted from finding information ...
Please provide your email address to receive an email when new articles are posted on . Return-to-play considerations and CVD risks of people who perform under life-threatening conditions were among ...
SOUTH SAN FRANCISCO, Calif., March 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (CYTK) today announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, ...
NEW ORLEANS , LA, UNITED STATES, March 19, 2026 /EINPresswire.com/ -- HeartLung.AI today announced that it will ...
The American College of Cardiology will host the New Orleans Health Fair on Saturday, March 21, 2026, to promote ...
Experts from the Smidt Heart Institute at Cedars-Sinai, California’s premier cardiology and heart surgery provider, will present innovative research findings and lead discussions on the latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results